Alpha Teknova, Inc. · NASDAQ:TKNO
Alpha Teknova — Q2 2022 Earnings Presentation
15 slides from Alpha Teknova's earnings presentation, Aug 10, 2022
Slide 1: Q2:2022 Financial Results Slide Supplement
Q2:2022 Financial Results Slide Supplement Nasdaq: TKNO August 10, 2022
Slide 2: Today's Agenda
Today’s Agenda 1. Welcome 2. Business Highlights & Updates — Stephen Gunstream, President and CEO 3. Financial Results — Matt Lowell, CFO 4. Q&A 2
Slide 3: Forward-looking Statements and Use of Non-GAAP Financial Measures
Forward-looking Statements and Use of Non-GAAP Financial Measures Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward- looking statements.” These statements include,
Slide 4: Business Highlights & Updates
Business Highlights & Updates Stephen Gunstream, President and CEO
Slide 5: Q2:2022 Business Highlights
Q2:2022 Business Highlights • Achieved record total quarterly revenue of $11.7 million, up 41%, compared to $8.3 million in the second quarter 2021 • Remained on track with capacity expansion of existing facilities and the construction of a new, state-of-the-art manufacturing facility • Reported cas
Slide 6: Financial Results
Q2:2022 Financial Results Matt Lowell, Chief Financial Officer
Slide 7: Q2:2022 Revenue Highlights
Q2:2022 Revenue Highlights Revenue by Category ($M) Key Highlights $11.7 • Total quarterly revenue up 41% y/y, excluding Sample Transport, $2.9 and 33% on a TTM basis over prior $8.3 year period $1.6 • Continued Lab Essentials growth, up 30% y/y and 18% on a TTM $8.4 basis over prior year period $6.
Slide 8: Q2:2022 Income Statement Highlights
Q2:2022 Income Statement Highlights Gross Margin (%) Total Opex ($M) 40.3% Q2:2021 44.9% GM% 48.7% $11.9 excl. one-time inventory $5.9 reserve Q2 2021 Q2 2022 Q2 2021 Q2 2022 Adjusted EBITDA1 ($M) Diluted EPS ($) ($1.5) ($0.22) ($4.9) ($0.52) Q2 2021 Q2 2022 Q2 2021 Q2 2022 8 1 Adjusted EBITDA is no
Slide 9: Q2:2022 Cash Flow & Balance Sheet Highlights
Q2:2022 Cash Flow & Balance Sheet Highlights Capital Expenditure ($M) Free Cash Flow1 ($M) ($8.2) ($16.8) $10.9 $4.7 Q2 2021 Q2 2022 Q2 2021 Q2 2022 Cash and Cash Equivalents $64.7M as of June 30, 2022 1 Free Cash Flow equals cash provided by (used in) operating activities less purchases of property
Slide 10: 2022 Guidance
2022 Guidance • Estimate total revenue between $38 – $42 million, ~13% growth y/y at the midpoint, excluding Sample Transport ▪ Approximately 10% y/y growth in Lab Essentials revenue ▪ At least 45% y/y growth in Clinical Solutions revenue • Will continue investing in 2022 in areas that drive future
Slide 11: Closing Comments
Closing Comments Stephen Gunstream, President and CEO
Slide 12: Q&A
Q&A
Slide 13: Supplemental Financials and Non-GAAP Reconciliations
Supplemental Financials and Non-GAAP Reconciliations
Slide 14: Financial Overview
Financial Overview TTM = Trailing Twelve Months Ended June 30, 2022 Total Revenue ($M) Gross Margin (%) $36.9 $42.3 $31.3 TTM GM% $35.4 $41.8 56.7% 2021 GM% $27.0 47.8% 48.9% excl. 46.9% 46.2% excl. one-time one-time inventory inventory reserve reserve 2020 2021 TTM Core ST 2020 2021 TTM Adjusted EB
Slide 15: Non-GAAP Reconciliations
Non-GAAP Reconciliations ALPHA TEKNOVA, INC. Reconciliation of Non-GAAP Measures to the Most Comparable GAAP Measures (unaudited) (in thousands) For the Three Months Ended June 30, For the Six Months Ended June 30, 2022 2021 2022 2021 Net loss – as reported $ (6,203) $ (2,250) $ (11,700) $ (2,905) A